近5年高被引文献
The 2022 hormone therapy position statement of The North American Menopause Society
article
Full Text
OpenAlex
528
FWCI100.583
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society
article
Full Text
OpenAlex
351
FWCI49.975
ESR1 mutation as an emerging clinical biomarker in metastatic hormone receptor-positive breast cancer
review
Full Text
OpenAlex
269
FWCI9.033
Antibody–drug conjugates: Recent advances in linker chemistry
review
Full Text
OpenAlex
236
FWCI6.75
Current Perspectives on the Beneficial Effects of Soybean Isoflavones and Their Metabolites for Humans
review
Full Text
OpenAlex
228
FWCI9.029
Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer
review
Full Text
OpenAlex
223
FWCI6.387
Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials
review
Full Text
OpenAlex
209
FWCI10.796
Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years
review
Full Text
OpenAlex
205
FWCI10.424
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
review
Full Text
OpenAlex
202
FWCI16.922
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
article
Full Text
OpenAlex
201
FWCI29.543